| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Muscle, Skeletal | 134 | 2025 | 671 | 20.450 |
Why?
|
| Diabetes Mellitus, Type 2 | 54 | 2024 | 675 | 8.730 |
Why?
|
| Glucose | 60 | 2024 | 444 | 8.500 |
Why?
|
| Exercise | 38 | 2025 | 909 | 6.910 |
Why?
|
| Insulin Resistance | 39 | 2024 | 403 | 6.100 |
Why?
|
| Insulin | 51 | 2024 | 686 | 5.310 |
Why?
|
| Obesity | 33 | 2024 | 1185 | 5.000 |
Why?
|
| Physical Conditioning, Animal | 18 | 2024 | 35 | 4.890 |
Why?
|
| Diet, High-Fat | 14 | 2024 | 159 | 4.800 |
Why?
|
| Energy Metabolism | 25 | 2024 | 348 | 4.570 |
Why?
|
| AMP-Activated Protein Kinases | 24 | 2018 | 64 | 4.490 |
Why?
|
| Diacylglycerol Kinase | 8 | 2024 | 10 | 4.160 |
Why?
|
| Muscle Fibers, Skeletal | 24 | 2025 | 84 | 3.430 |
Why?
|
| Lipid Metabolism | 16 | 2024 | 203 | 3.390 |
Why?
|
| Signal Transduction | 54 | 2025 | 2883 | 3.110 |
Why?
|
| Circadian Rhythm | 15 | 2024 | 370 | 2.800 |
Why?
|
| Adipose Tissue | 11 | 2024 | 283 | 2.440 |
Why?
|
| Animals | 104 | 2025 | 19554 | 2.400 |
Why?
|
| Mice | 75 | 2025 | 10232 | 2.260 |
Why?
|
| DNA Methylation | 10 | 2024 | 273 | 2.170 |
Why?
|
| Mice, Inbred C57BL | 32 | 2024 | 3183 | 2.050 |
Why?
|
| Adaptation, Physiological | 9 | 2023 | 115 | 1.930 |
Why?
|
| Mitochondria | 14 | 2024 | 333 | 1.870 |
Why?
|
| Transcriptome | 8 | 2022 | 322 | 1.790 |
Why?
|
| Epigenesis, Genetic | 9 | 2024 | 350 | 1.700 |
Why?
|
| Phosphorylation | 32 | 2021 | 860 | 1.700 |
Why?
|
| Muscle Contraction | 13 | 2024 | 198 | 1.660 |
Why?
|
| Circadian Clocks | 7 | 2023 | 44 | 1.650 |
Why?
|
| Male | 95 | 2025 | 27399 | 1.580 |
Why?
|
| Humans | 135 | 2025 | 59078 | 1.570 |
Why?
|
| Adenylate Kinase | 4 | 2017 | 15 | 1.570 |
Why?
|
| Diabetes Mellitus | 6 | 2019 | 532 | 1.550 |
Why?
|
| Blood Glucose | 17 | 2022 | 469 | 1.550 |
Why?
|
| Liver | 11 | 2024 | 781 | 1.540 |
Why?
|
| Phosphoproteins | 8 | 2021 | 216 | 1.370 |
Why?
|
| Multienzyme Complexes | 8 | 2008 | 77 | 1.370 |
Why?
|
| Glucose Tolerance Test | 11 | 2022 | 98 | 1.310 |
Why?
|
| RNA, Messenger | 17 | 2022 | 1466 | 1.310 |
Why?
|
| Mice, Transgenic | 12 | 2024 | 1220 | 1.250 |
Why?
|
| Promoter Regions, Genetic | 6 | 2024 | 656 | 1.180 |
Why?
|
| GTPase-Activating Proteins | 9 | 2016 | 63 | 1.160 |
Why?
|
| Insulin Receptor Substrate Proteins | 8 | 2021 | 58 | 1.150 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 16 | 2024 | 30 | 1.110 |
Why?
|
| Inflammation | 6 | 2022 | 1098 | 1.110 |
Why?
|
| Gene Expression Profiling | 9 | 2020 | 696 | 1.090 |
Why?
|
| Cardiovascular Diseases | 2 | 2024 | 826 | 1.080 |
Why?
|
| Aminoimidazole Carboxamide | 12 | 2017 | 13 | 1.060 |
Why?
|
| Hypoglycemic Agents | 8 | 2016 | 211 | 1.060 |
Why?
|
| Exercise Therapy | 4 | 2022 | 99 | 1.060 |
Why?
|
| Leptin | 4 | 2018 | 78 | 1.050 |
Why?
|
| Muscles | 3 | 2023 | 171 | 1.040 |
Why?
|
| Glycogen | 13 | 2017 | 46 | 1.020 |
Why?
|
| Ribonucleotides | 12 | 2017 | 15 | 1.020 |
Why?
|
| Glucose Intolerance | 5 | 2024 | 88 | 1.020 |
Why?
|
| Weight Loss | 4 | 2019 | 259 | 1.010 |
Why?
|
| Proteomics | 6 | 2025 | 252 | 0.990 |
Why?
|
| Proto-Oncogene Proteins c-akt | 12 | 2018 | 184 | 0.990 |
Why?
|
| Proteome | 7 | 2025 | 135 | 0.970 |
Why?
|
| Physical Endurance | 9 | 2021 | 48 | 0.970 |
Why?
|
| Rats | 20 | 2024 | 1904 | 0.970 |
Why?
|
| Cardiovascular System | 1 | 2024 | 40 | 0.870 |
Why?
|
| TOR Serine-Threonine Kinases | 5 | 2018 | 112 | 0.870 |
Why?
|
| Heat-Shock Proteins | 4 | 2013 | 66 | 0.860 |
Why?
|
| Diglycerides | 4 | 2017 | 22 | 0.860 |
Why?
|
| Urocortins | 2 | 2021 | 5 | 0.850 |
Why?
|
| Gene Expression | 15 | 2020 | 805 | 0.840 |
Why?
|
| Mice, Knockout | 16 | 2024 | 1985 | 0.830 |
Why?
|
| Metabolic Diseases | 3 | 2019 | 51 | 0.830 |
Why?
|
| Fatty Acids | 8 | 2024 | 194 | 0.820 |
Why?
|
| Transcription Factors | 16 | 2024 | 1453 | 0.810 |
Why?
|
| Precision Medicine | 2 | 2021 | 102 | 0.810 |
Why?
|
| Calcineurin | 3 | 2009 | 42 | 0.790 |
Why?
|
| Protein Kinase C | 6 | 2017 | 98 | 0.780 |
Why?
|
| Cells, Cultured | 20 | 2023 | 2092 | 0.770 |
Why?
|
| Clinical Trials as Topic | 1 | 2024 | 436 | 0.740 |
Why?
|
| Histones | 3 | 2022 | 463 | 0.720 |
Why?
|
| Enzyme Inhibitors | 6 | 2019 | 337 | 0.700 |
Why?
|
| Gene Silencing | 5 | 2012 | 377 | 0.680 |
Why?
|
| Epigenomics | 1 | 2020 | 54 | 0.670 |
Why?
|
| Homeostasis | 9 | 2022 | 340 | 0.670 |
Why?
|
| Forkhead Box Protein O1 | 2 | 2018 | 16 | 0.660 |
Why?
|
| Case-Control Studies | 10 | 2021 | 1054 | 0.660 |
Why?
|
| Circadian Rhythm Signaling Peptides and Proteins | 1 | 2019 | 3 | 0.650 |
Why?
|
| Paternal Inheritance | 1 | 2019 | 6 | 0.650 |
Why?
|
| Forkhead Box Protein O3 | 1 | 2018 | 8 | 0.640 |
Why?
|
| Motor Activity | 4 | 2019 | 342 | 0.630 |
Why?
|
| Tumor Necrosis Factor-alpha | 8 | 2019 | 580 | 0.630 |
Why?
|
| Mitochondrial Proteins | 9 | 2021 | 99 | 0.610 |
Why?
|
| Chemokines | 1 | 2018 | 94 | 0.610 |
Why?
|
| Gene Expression Regulation | 14 | 2018 | 1536 | 0.600 |
Why?
|
| Interleukin-6 | 7 | 2014 | 307 | 0.600 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2017 | 14 | 0.590 |
Why?
|
| Female | 41 | 2024 | 30709 | 0.580 |
Why?
|
| Protein Kinases | 6 | 2008 | 139 | 0.570 |
Why?
|
| Carboxylesterase | 1 | 2017 | 4 | 0.560 |
Why?
|
| Biopsy | 8 | 2021 | 373 | 0.560 |
Why?
|
| Death-Associated Protein Kinases | 1 | 2016 | 2 | 0.560 |
Why?
|
| Genomic Imprinting | 1 | 2017 | 49 | 0.560 |
Why?
|
| Adipose Tissue, Brown | 3 | 2024 | 100 | 0.560 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2016 | 13 | 0.560 |
Why?
|
| Middle Aged | 37 | 2024 | 16197 | 0.560 |
Why?
|
| Unfolded Protein Response | 1 | 2017 | 53 | 0.540 |
Why?
|
| Mitogen-Activated Protein Kinases | 6 | 2008 | 201 | 0.540 |
Why?
|
| MicroRNAs | 6 | 2021 | 617 | 0.540 |
Why?
|
| Protein Processing, Post-Translational | 3 | 2022 | 254 | 0.540 |
Why?
|
| Congresses as Topic | 1 | 2016 | 71 | 0.540 |
Why?
|
| Glucose Transporter Type 4 | 9 | 2018 | 56 | 0.530 |
Why?
|
| Science | 1 | 2016 | 33 | 0.530 |
Why?
|
| Pandemics | 1 | 2021 | 603 | 0.520 |
Why?
|
| Periodicals as Topic | 2 | 2015 | 170 | 0.520 |
Why?
|
| Diet | 3 | 2019 | 634 | 0.520 |
Why?
|
| Diabetes Mellitus, Experimental | 5 | 2015 | 195 | 0.510 |
Why?
|
| Nerve Tissue Proteins | 1 | 2018 | 422 | 0.510 |
Why?
|
| Resistance Training | 3 | 2020 | 20 | 0.510 |
Why?
|
| In Vitro Techniques | 8 | 2017 | 473 | 0.500 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2016 | 82 | 0.500 |
Why?
|
| Health | 1 | 2015 | 32 | 0.500 |
Why?
|
| Biological Transport | 11 | 2017 | 289 | 0.500 |
Why?
|
| Phosphotransferases | 2 | 2005 | 21 | 0.490 |
Why?
|
| DNA-Binding Proteins | 9 | 2021 | 1128 | 0.490 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2024 | 569 | 0.490 |
Why?
|
| Adipocytes | 6 | 2024 | 252 | 0.490 |
Why?
|
| Hyperglycemia | 3 | 2008 | 103 | 0.480 |
Why?
|
| Phosphatidylinositol 3-Kinases | 11 | 2007 | 164 | 0.480 |
Why?
|
| Subcutaneous Fat | 1 | 2015 | 50 | 0.480 |
Why?
|
| Mice, Obese | 6 | 2022 | 79 | 0.470 |
Why?
|
| Cell Differentiation | 4 | 2014 | 1291 | 0.470 |
Why?
|
| RNA, Small Interfering | 8 | 2021 | 850 | 0.470 |
Why?
|
| STAT3 Transcription Factor | 3 | 2018 | 68 | 0.460 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2014 | 124 | 0.450 |
Why?
|
| Fatty Acids, Nonesterified | 5 | 2019 | 55 | 0.450 |
Why?
|
| Research | 1 | 2015 | 190 | 0.450 |
Why?
|
| Nuclear Proteins | 4 | 2013 | 759 | 0.440 |
Why?
|
| Muscle Cells | 4 | 2019 | 27 | 0.440 |
Why?
|
| Triglycerides | 7 | 2019 | 245 | 0.430 |
Why?
|
| Adult | 33 | 2025 | 15680 | 0.420 |
Why?
|
| Computational Biology | 4 | 2020 | 324 | 0.420 |
Why?
|
| Aging | 3 | 2016 | 722 | 0.410 |
Why?
|
| Fasting | 4 | 2021 | 50 | 0.410 |
Why?
|
| Lipids | 6 | 2022 | 306 | 0.410 |
Why?
|
| Muscle Fibers, Fast-Twitch | 2 | 2009 | 10 | 0.400 |
Why?
|
| Amino Acids, Branched-Chain | 3 | 2021 | 13 | 0.390 |
Why?
|
| Gastric Bypass | 3 | 2019 | 74 | 0.370 |
Why?
|
| Ceramides | 2 | 2008 | 23 | 0.360 |
Why?
|
| Biomarkers | 5 | 2020 | 1202 | 0.360 |
Why?
|
| Cell Line | 8 | 2024 | 2011 | 0.350 |
Why?
|
| Tissue Extracts | 1 | 2010 | 13 | 0.350 |
Why?
|
| Oxidation-Reduction | 6 | 2024 | 303 | 0.350 |
Why?
|
| Carboxy-Lyases | 2 | 2018 | 6 | 0.350 |
Why?
|
| Glucose Transport Proteins, Facilitative | 1 | 2009 | 9 | 0.340 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2009 | 28 | 0.340 |
Why?
|
| Muscle Proteins | 4 | 2010 | 109 | 0.330 |
Why?
|
| Nicotinamide Phosphoribosyltransferase | 2 | 2023 | 4 | 0.330 |
Why?
|
| Twist-Related Protein 1 | 1 | 2009 | 12 | 0.330 |
Why?
|
| Blotting, Western | 8 | 2019 | 592 | 0.320 |
Why?
|
| Body Composition | 3 | 2019 | 153 | 0.320 |
Why?
|
| Trans-Activators | 5 | 2012 | 295 | 0.310 |
Why?
|
| Palmitic Acid | 3 | 2019 | 13 | 0.310 |
Why?
|
| Glycolysis | 6 | 2024 | 54 | 0.300 |
Why?
|
| Oxygen Consumption | 9 | 2024 | 197 | 0.300 |
Why?
|
| Quadriceps Muscle | 2 | 2018 | 15 | 0.300 |
Why?
|
| DNA, Mitochondrial | 2 | 2024 | 75 | 0.300 |
Why?
|
| Lipid Peroxidation | 3 | 2019 | 64 | 0.300 |
Why?
|
| Down-Regulation | 2 | 2010 | 304 | 0.300 |
Why?
|
| CpG Islands | 4 | 2015 | 212 | 0.290 |
Why?
|
| Lipolysis | 2 | 2024 | 47 | 0.280 |
Why?
|
| Palmitates | 2 | 2022 | 21 | 0.280 |
Why?
|
| Enzyme Activation | 8 | 2014 | 351 | 0.280 |
Why?
|
| Caloric Restriction | 2 | 2018 | 16 | 0.270 |
Why?
|
| Organ Specificity | 2 | 2020 | 178 | 0.270 |
Why?
|
| Physical Exertion | 2 | 2013 | 78 | 0.270 |
Why?
|
| Contractile Proteins | 1 | 2006 | 14 | 0.270 |
Why?
|
| Adenosine Monophosphate | 2 | 2005 | 26 | 0.270 |
Why?
|
| Gene Regulatory Networks | 2 | 2020 | 139 | 0.270 |
Why?
|
| Proto-Oncogene Proteins | 6 | 2005 | 315 | 0.270 |
Why?
|
| Pancreas Transplantation | 1 | 2006 | 21 | 0.260 |
Why?
|
| Period Circadian Proteins | 4 | 2020 | 71 | 0.260 |
Why?
|
| Creatine | 2 | 2024 | 26 | 0.260 |
Why?
|
| Protein Subunits | 5 | 2014 | 162 | 0.260 |
Why?
|
| Mitochondria, Muscle | 5 | 2024 | 12 | 0.260 |
Why?
|
| Kynurenine | 2 | 2016 | 6 | 0.250 |
Why?
|
| Microfilament Proteins | 1 | 2006 | 116 | 0.250 |
Why?
|
| Thermogenesis | 2 | 2024 | 108 | 0.250 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2021 | 673 | 0.250 |
Why?
|
| Isometric Contraction | 1 | 2005 | 45 | 0.250 |
Why?
|
| Extracellular Fluid | 1 | 2025 | 11 | 0.240 |
Why?
|
| Deoxyglucose | 4 | 2012 | 31 | 0.240 |
Why?
|
| Creatine Kinase, Mitochondrial Form | 1 | 2024 | 1 | 0.240 |
Why?
|
| Thiazolidinediones | 1 | 2005 | 51 | 0.240 |
Why?
|
| Hypoxia | 2 | 2022 | 107 | 0.240 |
Why?
|
| Glutaminase | 1 | 2024 | 2 | 0.240 |
Why?
|
| Hypertrophy | 2 | 2016 | 30 | 0.240 |
Why?
|
| 3T3-L1 Cells | 2 | 2023 | 83 | 0.240 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2004 | 67 | 0.230 |
Why?
|
| Metformin | 1 | 2005 | 67 | 0.230 |
Why?
|
| Overweight | 3 | 2020 | 247 | 0.230 |
Why?
|
| Mass Spectrometry | 3 | 2021 | 284 | 0.230 |
Why?
|
| Cross-Over Studies | 5 | 2022 | 148 | 0.230 |
Why?
|
| Tandem Mass Spectrometry | 2 | 2021 | 135 | 0.230 |
Why?
|
| beta-Alanine | 1 | 2003 | 9 | 0.220 |
Why?
|
| CLOCK Proteins | 3 | 2019 | 45 | 0.220 |
Why?
|
| Cardiac Output, Low | 1 | 2003 | 10 | 0.220 |
Why?
|
| Real-Time Polymerase Chain Reaction | 4 | 2017 | 191 | 0.220 |
Why?
|
| Alternative Splicing | 1 | 2024 | 121 | 0.220 |
Why?
|
| Cryptochromes | 3 | 2019 | 42 | 0.220 |
Why?
|
| Healthy Volunteers | 2 | 2021 | 72 | 0.210 |
Why?
|
| Oxidative Phosphorylation | 3 | 2024 | 34 | 0.210 |
Why?
|
| Organ Size | 2 | 2016 | 163 | 0.210 |
Why?
|
| Hindlimb | 1 | 2023 | 43 | 0.210 |
Why?
|
| NAD | 1 | 2023 | 45 | 0.210 |
Why?
|
| Bicycling | 1 | 2003 | 24 | 0.210 |
Why?
|
| Chemokine CXCL12 | 1 | 2022 | 15 | 0.210 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2013 | 322 | 0.210 |
Why?
|
| Histone Code | 1 | 2022 | 25 | 0.210 |
Why?
|
| Calcium | 2 | 2020 | 550 | 0.210 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2004 | 158 | 0.210 |
Why?
|
| MAP Kinase Signaling System | 1 | 2004 | 201 | 0.210 |
Why?
|
| Boronic Acids | 2 | 2014 | 27 | 0.210 |
Why?
|
| Pyrazines | 2 | 2014 | 32 | 0.200 |
Why?
|
| Isoenzymes | 5 | 2009 | 134 | 0.200 |
Why?
|
| ARNTL Transcription Factors | 2 | 2019 | 25 | 0.200 |
Why?
|
| Gene Ontology | 2 | 2020 | 37 | 0.200 |
Why?
|
| Receptor, Insulin | 3 | 2010 | 47 | 0.200 |
Why?
|
| Gene Expression Regulation, Enzymologic | 3 | 2014 | 130 | 0.200 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 2 | 2017 | 22 | 0.200 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2004 | 208 | 0.200 |
Why?
|
| PPAR delta | 3 | 2006 | 9 | 0.200 |
Why?
|
| Adipocytes, White | 1 | 2022 | 27 | 0.200 |
Why?
|
| Neuronal Outgrowth | 1 | 2021 | 10 | 0.200 |
Why?
|
| Primary Cell Culture | 2 | 2019 | 75 | 0.200 |
Why?
|
| Thymosin | 1 | 2021 | 8 | 0.190 |
Why?
|
| Cytokines | 2 | 2023 | 904 | 0.190 |
Why?
|
| Transcription, Genetic | 2 | 2024 | 847 | 0.190 |
Why?
|
| Pyrones | 3 | 2012 | 6 | 0.190 |
Why?
|
| Glucagon | 2 | 2014 | 34 | 0.190 |
Why?
|
| Rats, Wistar | 5 | 2017 | 178 | 0.190 |
Why?
|
| Thermotolerance | 1 | 2021 | 2 | 0.190 |
Why?
|
| NF-kappa B | 3 | 2019 | 461 | 0.190 |
Why?
|
| Acetyl-CoA Carboxylase | 3 | 2014 | 13 | 0.190 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 2 | 2012 | 22 | 0.190 |
Why?
|
| Autocrine Communication | 2 | 2013 | 31 | 0.190 |
Why?
|
| Combined Modality Therapy | 1 | 2022 | 349 | 0.190 |
Why?
|
| Thiophenes | 3 | 2012 | 43 | 0.180 |
Why?
|
| Endothelial Cells | 1 | 2022 | 175 | 0.180 |
Why?
|
| Chromatography, Liquid | 1 | 2021 | 119 | 0.180 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2022 | 69 | 0.180 |
Why?
|
| Receptors, Estrogen | 1 | 2021 | 124 | 0.180 |
Why?
|
| Thinness | 2 | 2018 | 38 | 0.180 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2020 | 18 | 0.180 |
Why?
|
| Osteoblasts | 1 | 2021 | 204 | 0.180 |
Why?
|
| Cell Proliferation | 2 | 2021 | 936 | 0.170 |
Why?
|
| Receptors, Steroid | 1 | 2020 | 24 | 0.170 |
Why?
|
| Receptors, Thyroid Hormone | 1 | 2020 | 25 | 0.170 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 6 | 2010 | 125 | 0.170 |
Why?
|
| Young Adult | 9 | 2021 | 4303 | 0.170 |
Why?
|
| Eating | 1 | 2020 | 139 | 0.170 |
Why?
|
| Amino Acids | 1 | 2020 | 140 | 0.170 |
Why?
|
| Carboxylic Ester Hydrolases | 2 | 2017 | 11 | 0.170 |
Why?
|
| Nutritional Status | 1 | 2020 | 118 | 0.170 |
Why?
|
| Time Factors | 9 | 2018 | 3554 | 0.160 |
Why?
|
| Electroporation | 1 | 2019 | 31 | 0.160 |
Why?
|
| Patient Compliance | 1 | 2022 | 371 | 0.160 |
Why?
|
| HEK293 Cells | 2 | 2019 | 567 | 0.160 |
Why?
|
| Healthy Lifestyle | 1 | 2019 | 29 | 0.160 |
Why?
|
| Exercise Tolerance | 1 | 2019 | 68 | 0.160 |
Why?
|
| Mental Health | 1 | 2022 | 346 | 0.160 |
Why?
|
| Carotid Intima-Media Thickness | 2 | 2015 | 9 | 0.160 |
Why?
|
| Metabolism | 1 | 2018 | 14 | 0.160 |
Why?
|
| Metabolic Networks and Pathways | 2 | 2017 | 72 | 0.160 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2020 | 248 | 0.160 |
Why?
|
| Sphingolipids | 1 | 2018 | 22 | 0.150 |
Why?
|
| Epoxy Compounds | 1 | 2018 | 9 | 0.150 |
Why?
|
| Health Behavior | 1 | 2022 | 472 | 0.150 |
Why?
|
| Immunoblotting | 3 | 2008 | 189 | 0.150 |
Why?
|
| Exosomes | 1 | 2018 | 42 | 0.150 |
Why?
|
| Running | 1 | 2019 | 80 | 0.150 |
Why?
|
| DNA | 1 | 2022 | 787 | 0.150 |
Why?
|
| Peptides | 1 | 2021 | 547 | 0.150 |
Why?
|
| Activating Transcription Factor 6 | 1 | 2017 | 3 | 0.150 |
Why?
|
| Amino Acid Sequence | 1 | 2021 | 1577 | 0.140 |
Why?
|
| Glucose Clamp Technique | 4 | 2005 | 58 | 0.140 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2016 | 14 | 0.140 |
Why?
|
| Bortezomib | 2 | 2014 | 54 | 0.140 |
Why?
|
| Prevalence | 1 | 2021 | 1278 | 0.140 |
Why?
|
| Gene Knockout Techniques | 1 | 2017 | 89 | 0.140 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2017 | 38 | 0.140 |
Why?
|
| Social Networking | 1 | 2016 | 23 | 0.140 |
Why?
|
| Gene Knockdown Techniques | 1 | 2017 | 192 | 0.140 |
Why?
|
| Kinetics | 5 | 2013 | 732 | 0.130 |
Why?
|
| Career Mobility | 1 | 2016 | 60 | 0.130 |
Why?
|
| Suppressor of Cytokine Signaling 3 Protein | 2 | 2012 | 8 | 0.130 |
Why?
|
| Protein Isoforms | 3 | 2024 | 193 | 0.130 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 2 | 2012 | 14 | 0.130 |
Why?
|
| Disease Models, Animal | 3 | 2021 | 2053 | 0.130 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 3 | 2016 | 180 | 0.130 |
Why?
|
| Athletes | 1 | 2017 | 96 | 0.130 |
Why?
|
| PPAR alpha | 3 | 2016 | 28 | 0.130 |
Why?
|
| Sleep Deprivation | 1 | 2015 | 16 | 0.130 |
Why?
|
| Fatty Acid Transport Proteins | 2 | 2018 | 7 | 0.130 |
Why?
|
| Hepatocytes | 1 | 2017 | 187 | 0.130 |
Why?
|
| Biphenyl Compounds | 3 | 2012 | 29 | 0.130 |
Why?
|
| Walking | 2 | 2015 | 229 | 0.120 |
Why?
|
| Bariatric Surgery | 1 | 2015 | 45 | 0.120 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 2 | 2007 | 40 | 0.120 |
Why?
|
| Transfection | 4 | 2015 | 671 | 0.120 |
Why?
|
| Protein Biosynthesis | 1 | 2017 | 291 | 0.120 |
Why?
|
| Carotid Arteries | 1 | 2015 | 59 | 0.120 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 2 | 2007 | 44 | 0.120 |
Why?
|
| Cooperative Behavior | 1 | 2016 | 217 | 0.120 |
Why?
|
| Electric Stimulation | 2 | 2005 | 139 | 0.120 |
Why?
|
| Monosaccharide Transport Proteins | 3 | 2003 | 40 | 0.120 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2014 | 10 | 0.120 |
Why?
|
| Mutation | 2 | 2018 | 2421 | 0.120 |
Why?
|
| Protein Carbonylation | 1 | 2014 | 1 | 0.120 |
Why?
|
| History, 21st Century | 1 | 2015 | 161 | 0.120 |
Why?
|
| Algorithms | 1 | 2020 | 985 | 0.120 |
Why?
|
| Proteasome Inhibitors | 1 | 2014 | 30 | 0.120 |
Why?
|
| Vascular Stiffness | 1 | 2014 | 14 | 0.120 |
Why?
|
| Manometry | 1 | 2014 | 21 | 0.120 |
Why?
|
| Sequence Analysis, DNA | 2 | 2013 | 394 | 0.120 |
Why?
|
| Risk Factors | 3 | 2021 | 4990 | 0.120 |
Why?
|
| History, 20th Century | 1 | 2015 | 226 | 0.120 |
Why?
|
| Methotrexate | 1 | 2014 | 76 | 0.120 |
Why?
|
| Oxidative Stress | 2 | 2014 | 279 | 0.120 |
Why?
|
| Angiography | 1 | 2014 | 145 | 0.110 |
Why?
|
| RNA Interference | 2 | 2014 | 588 | 0.110 |
Why?
|
| Interleukin-13 | 1 | 2013 | 35 | 0.110 |
Why?
|
| Anti-Obesity Agents | 1 | 2013 | 11 | 0.110 |
Why?
|
| Cell Hypoxia | 2 | 2012 | 39 | 0.110 |
Why?
|
| Transcription Initiation Site | 1 | 2013 | 48 | 0.110 |
Why?
|
| Muscle Development | 1 | 2013 | 53 | 0.110 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 2 | 2010 | 30 | 0.110 |
Why?
|
| Models, Biological | 4 | 2020 | 1137 | 0.110 |
Why?
|
| Glutamine | 2 | 2024 | 47 | 0.110 |
Why?
|
| Janus Kinase 2 | 1 | 2012 | 13 | 0.100 |
Why?
|
| Obesity, Morbid | 1 | 2014 | 90 | 0.100 |
Why?
|
| Gluconeogenesis | 1 | 2012 | 15 | 0.100 |
Why?
|
| Sleep | 1 | 2015 | 218 | 0.100 |
Why?
|
| Genetic Variation | 1 | 2014 | 367 | 0.100 |
Why?
|
| Fibroblasts | 2 | 2011 | 366 | 0.100 |
Why?
|
| Immunohistochemistry | 2 | 2013 | 846 | 0.100 |
Why?
|
| Genome, Human | 1 | 2013 | 218 | 0.090 |
Why?
|
| Body Weight | 2 | 2009 | 378 | 0.090 |
Why?
|
| Genetic Vectors | 1 | 2017 | 796 | 0.090 |
Why?
|
| Fibroblast Growth Factors | 1 | 2011 | 63 | 0.090 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2009 | 168 | 0.090 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2010 | 11 | 0.090 |
Why?
|
| Stress, Psychological | 1 | 2014 | 442 | 0.090 |
Why?
|
| Base Sequence | 2 | 2010 | 1309 | 0.090 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2010 | 41 | 0.090 |
Why?
|
| Sirtuin 1 | 1 | 2010 | 23 | 0.090 |
Why?
|
| Diacylglycerol O-Acyltransferase | 1 | 2009 | 12 | 0.090 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2010 | 141 | 0.090 |
Why?
|
| Ion Channels | 2 | 2008 | 86 | 0.080 |
Why?
|
| Electron Transport | 1 | 2009 | 34 | 0.080 |
Why?
|
| Acyltransferases | 1 | 2009 | 32 | 0.080 |
Why?
|
| Benzylamines | 1 | 2009 | 25 | 0.080 |
Why?
|
| Forkhead Transcription Factors | 1 | 2010 | 117 | 0.080 |
Why?
|
| Protease Inhibitors | 1 | 2010 | 104 | 0.080 |
Why?
|
| Calorimetry, Indirect | 3 | 2019 | 32 | 0.080 |
Why?
|
| Genome-Wide Association Study | 3 | 2016 | 321 | 0.080 |
Why?
|
| Body Mass Index | 4 | 2011 | 891 | 0.080 |
Why?
|
| Hyperlipidemias | 1 | 2009 | 38 | 0.080 |
Why?
|
| Killer Cells, Natural | 1 | 2010 | 215 | 0.080 |
Why?
|
| Ionophores | 1 | 2008 | 10 | 0.080 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2006 | 70 | 0.080 |
Why?
|
| Ionomycin | 1 | 2008 | 15 | 0.080 |
Why?
|
| Sulfonamides | 1 | 2009 | 123 | 0.080 |
Why?
|
| PPAR gamma | 1 | 2009 | 71 | 0.080 |
Why?
|
| Organ Culture Techniques | 1 | 2008 | 70 | 0.080 |
Why?
|
| 11-beta-Hydroxysteroid Dehydrogenase Type 1 | 2 | 2009 | 3 | 0.080 |
Why?
|
| Adipose Tissue, White | 1 | 2009 | 82 | 0.080 |
Why?
|
| Membrane Proteins | 2 | 2005 | 839 | 0.080 |
Why?
|
| C-Peptide | 2 | 2005 | 23 | 0.080 |
Why?
|
| Coenzyme A | 1 | 2008 | 6 | 0.080 |
Why?
|
| Glucagon-Secreting Cells | 1 | 2008 | 26 | 0.080 |
Why?
|
| I-kappa B Kinase | 1 | 2008 | 48 | 0.080 |
Why?
|
| Acetyl Coenzyme A | 1 | 2008 | 23 | 0.080 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 2 | 2005 | 19 | 0.070 |
Why?
|
| Glutamic Acid | 1 | 2008 | 98 | 0.070 |
Why?
|
| Atherosclerosis | 1 | 2009 | 147 | 0.070 |
Why?
|
| Depression | 1 | 2014 | 856 | 0.070 |
Why?
|
| Protein Kinase C-delta | 2 | 2004 | 6 | 0.070 |
Why?
|
| Filamins | 1 | 2006 | 7 | 0.070 |
Why?
|
| Rats, Zucker | 2 | 2003 | 7 | 0.070 |
Why?
|
| Dietary Fats | 2 | 2006 | 204 | 0.070 |
Why?
|
| Serine | 1 | 2006 | 83 | 0.060 |
Why?
|
| Transaminases | 2 | 2016 | 11 | 0.060 |
Why?
|
| Myoblasts | 1 | 2006 | 63 | 0.060 |
Why?
|
| Biological Transport, Active | 1 | 2005 | 39 | 0.060 |
Why?
|
| Physical Fitness | 1 | 2005 | 92 | 0.060 |
Why?
|
| Multiple Myeloma | 1 | 2010 | 320 | 0.060 |
Why?
|
| Cathelicidins | 1 | 2025 | 7 | 0.060 |
Why?
|
| Pulse Wave Analysis | 2 | 2015 | 10 | 0.060 |
Why?
|
| Drug Resistance | 1 | 2005 | 97 | 0.060 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2009 | 606 | 0.060 |
Why?
|
| Allosteric Regulation | 1 | 2005 | 69 | 0.060 |
Why?
|
| Feedback, Physiological | 1 | 2005 | 58 | 0.060 |
Why?
|
| Muscle Fibers, Slow-Twitch | 1 | 2004 | 4 | 0.060 |
Why?
|
| United Kingdom | 1 | 2005 | 69 | 0.060 |
Why?
|
| Biotechnology | 1 | 2005 | 42 | 0.060 |
Why?
|
| Muscle Fatigue | 1 | 2005 | 45 | 0.060 |
Why?
|
| Drug Industry | 1 | 2005 | 40 | 0.060 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2025 | 54 | 0.060 |
Why?
|
| Muscular Atrophy | 1 | 2004 | 26 | 0.060 |
Why?
|
| Blood | 1 | 2004 | 27 | 0.060 |
Why?
|
| Immunosuppressive Agents | 1 | 2006 | 291 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-cbl | 1 | 2004 | 8 | 0.060 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2004 | 27 | 0.060 |
Why?
|
| Adiponectin | 1 | 2004 | 34 | 0.060 |
Why?
|
| 3-Phosphoinositide-Dependent Protein Kinases | 1 | 2003 | 4 | 0.060 |
Why?
|
| Rats, Mutant Strains | 1 | 2003 | 10 | 0.060 |
Why?
|
| Protein Kinase C beta | 1 | 2003 | 6 | 0.060 |
Why?
|
| Protein Kinase C-alpha | 1 | 2003 | 16 | 0.060 |
Why?
|
| Oleic Acid | 1 | 2003 | 22 | 0.060 |
Why?
|
| Phosphotyrosine | 1 | 2003 | 23 | 0.060 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2004 | 123 | 0.060 |
Why?
|
| Protein Kinase C-theta | 1 | 2003 | 16 | 0.060 |
Why?
|
| Sports | 1 | 2004 | 92 | 0.060 |
Why?
|
| Kidney Transplantation | 1 | 2006 | 257 | 0.050 |
Why?
|
| Islets of Langerhans | 1 | 2005 | 267 | 0.050 |
Why?
|
| Adenosine Triphosphate | 1 | 2005 | 286 | 0.050 |
Why?
|
| Physical Education and Training | 1 | 2003 | 31 | 0.050 |
Why?
|
| Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2003 | 4 | 0.050 |
Why?
|
| Fatty Liver | 1 | 2024 | 98 | 0.050 |
Why?
|
| Tyrosine | 1 | 2003 | 95 | 0.050 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2003 | 33 | 0.050 |
Why?
|
| Regional Blood Flow | 1 | 2003 | 107 | 0.050 |
Why?
|
| Protein Transport | 2 | 2018 | 393 | 0.050 |
Why?
|
| Cell Line, Tumor | 2 | 2021 | 1363 | 0.050 |
Why?
|
| Metabolome | 1 | 2022 | 23 | 0.050 |
Why?
|
| Aged | 5 | 2022 | 13267 | 0.050 |
Why?
|
| Phosphocreatine | 1 | 2022 | 24 | 0.050 |
Why?
|
| Incretins | 1 | 2022 | 6 | 0.050 |
Why?
|
| Blood Pressure | 2 | 2015 | 519 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase 6 | 1 | 2021 | 1 | 0.050 |
Why?
|
| Up-Regulation | 2 | 2015 | 362 | 0.050 |
Why?
|
| Metabolomics | 1 | 2022 | 50 | 0.050 |
Why?
|
| Muscular Diseases | 1 | 2021 | 45 | 0.050 |
Why?
|
| Endosomal Sorting Complexes Required for Transport | 1 | 2021 | 53 | 0.050 |
Why?
|
| Stroke Volume | 1 | 2003 | 317 | 0.050 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2021 | 54 | 0.050 |
Why?
|
| Hydrocortisone | 2 | 2015 | 188 | 0.050 |
Why?
|
| Reference Values | 3 | 2007 | 322 | 0.050 |
Why?
|
| Nuclear Respiratory Factor 1 | 2 | 2013 | 3 | 0.050 |
Why?
|
| Phenotype | 1 | 2004 | 1153 | 0.050 |
Why?
|
| Exercise Test | 3 | 2010 | 232 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2014 | 1540 | 0.040 |
Why?
|
| Mutation, Missense | 2 | 2015 | 179 | 0.040 |
Why?
|
| Pancreatic Neoplasms | 1 | 2003 | 315 | 0.040 |
Why?
|
| Chronic Disease | 1 | 2003 | 731 | 0.040 |
Why?
|
| Species Specificity | 1 | 2019 | 335 | 0.040 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2019 | 30 | 0.040 |
Why?
|
| Stearoyl-CoA Desaturase | 1 | 2018 | 9 | 0.040 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2020 | 131 | 0.040 |
Why?
|
| Phosphatidylcholines | 1 | 2018 | 35 | 0.040 |
Why?
|
| Cholesterol, HDL | 1 | 2018 | 78 | 0.040 |
Why?
|
| Cholesterol, LDL | 1 | 2018 | 105 | 0.040 |
Why?
|
| Adiposity | 1 | 2019 | 81 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2013 | 522 | 0.040 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2018 | 148 | 0.040 |
Why?
|
| Sequence Analysis, RNA | 1 | 2019 | 151 | 0.040 |
Why?
|
| Proteins | 1 | 2004 | 742 | 0.040 |
Why?
|
| Uncoupling Protein 3 | 2 | 2008 | 3 | 0.040 |
Why?
|
| Weight Gain | 1 | 2019 | 161 | 0.040 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2017 | 13 | 0.040 |
Why?
|
| Glycogen Synthase | 1 | 2016 | 4 | 0.030 |
Why?
|
| Sweden | 1 | 2016 | 40 | 0.030 |
Why?
|
| Cell Membrane | 2 | 2009 | 489 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2018 | 5129 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2018 | 415 | 0.030 |
Why?
|
| Software | 1 | 2019 | 365 | 0.030 |
Why?
|
| RNA, Small Untranslated | 1 | 2015 | 17 | 0.030 |
Why?
|
| Histidine | 1 | 2015 | 31 | 0.030 |
Why?
|
| Blood Pressure Determination | 1 | 2015 | 43 | 0.030 |
Why?
|
| Transcription Factor 7-Like 2 Protein | 1 | 2015 | 2 | 0.030 |
Why?
|
| Waist Circumference | 1 | 2015 | 55 | 0.030 |
Why?
|
| Genetic Markers | 1 | 2015 | 120 | 0.030 |
Why?
|
| Nucleic Acid Synthesis Inhibitors | 1 | 2014 | 13 | 0.030 |
Why?
|
| Kynurenic Acid | 1 | 2014 | 2 | 0.030 |
Why?
|
| Physical Conditioning, Human | 1 | 2014 | 2 | 0.030 |
Why?
|
| Arginine | 1 | 2015 | 113 | 0.030 |
Why?
|
| Amino Acid Substitution | 1 | 2015 | 251 | 0.030 |
Why?
|
| Greenland | 1 | 2014 | 1 | 0.030 |
Why?
|
| 3' Untranslated Regions | 1 | 2014 | 84 | 0.030 |
Why?
|
| Carotid Artery, Common | 1 | 2014 | 30 | 0.030 |
Why?
|
| Vascular Resistance | 1 | 2014 | 44 | 0.030 |
Why?
|
| Genetic Loci | 1 | 2015 | 106 | 0.030 |
Why?
|
| Gene Frequency | 1 | 2014 | 131 | 0.030 |
Why?
|
| Codon, Nonsense | 1 | 2014 | 51 | 0.030 |
Why?
|
| Blood-Brain Barrier | 1 | 2014 | 82 | 0.030 |
Why?
|
| GTP Phosphohydrolases | 2 | 2005 | 59 | 0.030 |
Why?
|
| Culture Media, Conditioned | 1 | 2013 | 50 | 0.030 |
Why?
|
| Sex Characteristics | 1 | 2015 | 199 | 0.030 |
Why?
|
| Central Nervous System | 1 | 2015 | 190 | 0.030 |
Why?
|
| Karyopherins | 1 | 2013 | 7 | 0.030 |
Why?
|
| Hypertriglyceridemia | 1 | 2013 | 10 | 0.030 |
Why?
|
| Hemodynamics | 1 | 2014 | 217 | 0.030 |
Why?
|
| Carbon Dioxide | 1 | 2013 | 75 | 0.030 |
Why?
|
| Ribonuclease III | 1 | 2013 | 81 | 0.030 |
Why?
|
| Histone Deacetylases | 1 | 2013 | 62 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2013 | 158 | 0.030 |
Why?
|
| Receptors, Interleukin-6 | 1 | 2012 | 14 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2013 | 304 | 0.030 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2013 | 76 | 0.030 |
Why?
|
| Motor Neurons | 1 | 2014 | 206 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2015 | 459 | 0.030 |
Why?
|
| Genotype | 1 | 2014 | 642 | 0.030 |
Why?
|
| Interleukin-1beta | 1 | 2014 | 261 | 0.030 |
Why?
|
| Animal Nutritional Physiological Phenomena | 1 | 2012 | 4 | 0.030 |
Why?
|
| Mitochondria, Liver | 1 | 2012 | 10 | 0.030 |
Why?
|
| High Mobility Group Proteins | 1 | 2012 | 17 | 0.020 |
Why?
|
| Methylation | 1 | 2012 | 126 | 0.020 |
Why?
|
| Sulfites | 1 | 2011 | 7 | 0.020 |
Why?
|
| DNA Cleavage | 1 | 2011 | 17 | 0.020 |
Why?
|
| Prognosis | 1 | 2016 | 1563 | 0.020 |
Why?
|
| Luminescent Measurements | 1 | 2011 | 37 | 0.020 |
Why?
|
| Cytosine | 1 | 2011 | 30 | 0.020 |
Why?
|
| Glycoproteins | 1 | 2012 | 192 | 0.020 |
Why?
|
| Two-Dimensional Difference Gel Electrophoresis | 1 | 2011 | 2 | 0.020 |
Why?
|
| Repressor Proteins | 1 | 2013 | 335 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2012 | 247 | 0.020 |
Why?
|
| Glucose Transporter Type 1 | 1 | 2011 | 50 | 0.020 |
Why?
|
| Risk Reduction Behavior | 1 | 2011 | 125 | 0.020 |
Why?
|
| Killer Cells, Lymphokine-Activated | 1 | 2010 | 1 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2016 | 2317 | 0.020 |
Why?
|
| Cell Degranulation | 1 | 2010 | 20 | 0.020 |
Why?
|
| Mice, Inbred NOD | 1 | 2012 | 510 | 0.020 |
Why?
|
| K562 Cells | 1 | 2010 | 58 | 0.020 |
Why?
|
| Activating Transcription Factor 2 | 1 | 2010 | 10 | 0.020 |
Why?
|
| Genes, Mitochondrial | 1 | 2010 | 4 | 0.020 |
Why?
|
| RNA-Binding Proteins | 1 | 2013 | 384 | 0.020 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2010 | 44 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2011 | 498 | 0.020 |
Why?
|
| Ouabain | 1 | 2009 | 6 | 0.020 |
Why?
|
| Interleukin-2 | 1 | 2010 | 163 | 0.020 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2010 | 87 | 0.020 |
Why?
|
| DNA Primers | 1 | 2010 | 292 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2016 | 3080 | 0.020 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2009 | 28 | 0.020 |
Why?
|
| Adipokines | 1 | 2009 | 28 | 0.020 |
Why?
|
| Chemokine CCL2 | 1 | 2009 | 54 | 0.020 |
Why?
|
| Pyrimidines | 1 | 2009 | 123 | 0.020 |
Why?
|
| Pyrazoles | 1 | 2009 | 73 | 0.020 |
Why?
|
| Nuclear Receptor Subfamily 1, Group D, Member 1 | 1 | 2008 | 1 | 0.020 |
Why?
|
| Exocytosis | 1 | 2009 | 60 | 0.020 |
Why?
|
| Hexokinase | 1 | 2008 | 11 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2013 | 714 | 0.020 |
Why?
|
| Apolipoproteins E | 1 | 2009 | 99 | 0.020 |
Why?
|
| Flavoproteins | 1 | 2008 | 29 | 0.020 |
Why?
|
| Receptors, Kainic Acid | 1 | 2008 | 2 | 0.020 |
Why?
|
| Haplorhini | 1 | 2008 | 14 | 0.020 |
Why?
|
| Oncogene Protein v-akt | 1 | 2008 | 15 | 0.020 |
Why?
|
| Lipogenesis | 1 | 2009 | 65 | 0.020 |
Why?
|
| CD4 Antigens | 1 | 2009 | 154 | 0.020 |
Why?
|
| Receptors, AMPA | 1 | 2008 | 40 | 0.020 |
Why?
|
| Receptors, Metabotropic Glutamate | 1 | 2008 | 30 | 0.020 |
Why?
|
| Carbohydrate Metabolism | 1 | 2008 | 48 | 0.020 |
Why?
|
| Inflammation Mediators | 1 | 2009 | 169 | 0.020 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2008 | 124 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2009 | 807 | 0.020 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2008 | 140 | 0.020 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2007 | 28 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2008 | 291 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 2009 | 536 | 0.020 |
Why?
|
| Homeodomain Proteins | 1 | 2008 | 254 | 0.020 |
Why?
|
| Body Size | 1 | 2006 | 23 | 0.020 |
Why?
|
| Polymorphism, Genetic | 1 | 2007 | 197 | 0.020 |
Why?
|
| Eukaryotic Initiation Factor-2B | 1 | 2005 | 2 | 0.020 |
Why?
|
| Blood Chemical Analysis | 1 | 2006 | 20 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2008 | 374 | 0.020 |
Why?
|
| Charcot-Marie-Tooth Disease | 1 | 2005 | 7 | 0.020 |
Why?
|
| Deuterium | 1 | 2005 | 23 | 0.020 |
Why?
|
| Placebos | 1 | 2005 | 72 | 0.020 |
Why?
|
| Cytoskeletal Proteins | 1 | 2006 | 194 | 0.020 |
Why?
|
| Thiazoles | 1 | 2005 | 47 | 0.020 |
Why?
|
| Apoptosis | 1 | 2010 | 1034 | 0.020 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2005 | 74 | 0.010 |
Why?
|
| Imidazoles | 1 | 2005 | 84 | 0.010 |
Why?
|
| Flavonoids | 1 | 2005 | 73 | 0.010 |
Why?
|
| Pyridines | 1 | 2005 | 97 | 0.010 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2005 | 186 | 0.010 |
Why?
|
| Family | 1 | 2006 | 216 | 0.010 |
Why?
|
| Metabolic Syndrome | 1 | 2006 | 150 | 0.010 |
Why?
|
| MADS Domain Proteins | 1 | 2004 | 2 | 0.010 |
Why?
|
| MEF2 Transcription Factors | 1 | 2004 | 10 | 0.010 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2004 | 15 | 0.010 |
Why?
|
| Myogenic Regulatory Factors | 1 | 2004 | 12 | 0.010 |
Why?
|
| Osmotic Pressure | 1 | 2004 | 15 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2004 | 166 | 0.010 |
Why?
|
| COS Cells | 1 | 2004 | 176 | 0.010 |
Why?
|
| Protein Kinase C-epsilon | 1 | 2004 | 12 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2004 | 52 | 0.010 |
Why?
|
| Fat Emulsions, Intravenous | 1 | 2004 | 36 | 0.010 |
Why?
|
| Swine | 1 | 2004 | 337 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2005 | 691 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2004 | 253 | 0.010 |
Why?
|
| 3-O-Methylglucose | 1 | 2003 | 16 | 0.010 |
Why?
|
| Temperature | 1 | 2004 | 300 | 0.010 |
Why?
|
| Cytosol | 1 | 2004 | 167 | 0.010 |
Why?
|
| Administration, Oral | 1 | 2004 | 344 | 0.010 |
Why?
|
| Membrane Potentials | 1 | 2003 | 136 | 0.010 |
Why?
|
| Lipodystrophy | 1 | 2002 | 11 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2006 | 1972 | 0.010 |
Why?
|